Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05854992 · ClinicalTrials.gov registry record
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 68,419
- Enrollment target
NCT05854992: Completed study, sponsored by Mayo Clinic.
NCT05854992 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 68,419 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05854992 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 68,419 participants
- Enrollment target
Study Summary
Researchers are evaluating the safety of triptan treatment of migraine in individuals with elevated cardiovascular risk and in pregnant women.
Interventions
- DRUG Acute migraine treatment with any prescribed triptans
- DRUG Standard of care management of acute migraine without triptans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68,419 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2024-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05854992
The ClinicalTrials.gov registry entry for NCT05854992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68,419 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acute migraine treatment with any prescribed triptans is the first listed.
NCT05854992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05854992 about?
NCT05854992 is a clinical study titled "Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women". Researchers are evaluating the safety of triptan treatment of migraine in individuals with elevated cardiovascular risk and in pregnant women.
What is the current status of trial NCT05854992?
This trial is currently completed. The enrollment target is 68,419 participants. The study started on 2022-07-05. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT05854992?
The interventions under investigation include: Acute migraine treatment with any prescribed triptans (DRUG), Standard of care management of acute migraine without triptans (DRUG).
Who is sponsoring clinical trial NCT05854992?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.